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Transcription factors (TFs) regulate gene expression in living organisms. In higher
organisms, TFs often interact in non-random combinations with each other to control
gene transcription. Understanding the interactions is key to decipher mechanisms
underlying tissue development. The aim of this study was to analyze co-occurring
transcription factor binding sites (TFBSs) in a time series dataset from a new cell-culture
model of human heart muscle development in order to identify common as well as
specific co-occurring TFBS pairs in the promoter regions of regulated genes which
can be essential to enhance cardiac tissue developmental processes. To this end, we
separated available RNAseq dataset into five temporally defined groups: (i) mesoderm
induction stage; (ii) early cardiac specification stage; (iii) late cardiac specification stage;
(iv) early cardiac maturation stage; (v) late cardiac maturation stage, where each of
these stages is characterized by unique differentially expressed genes (DEGs). To identify
TFBS pairs for each stage, we applied the MatrixCatch algorithm, which is a successful
method to deduce experimentally described TFBS pairs in the promoters of the DEGs.
Although DEGs in each stage are distinct, our results show that the TFBS pair networks
predicted by MatrixCatch for all stages are quite similar. Thus, we extend the results of
MatrixCatch utilizing a Markov clustering algorithm (MCL) to perform network analysis.
Using our extended approach, we are able to separate the TFBS pair networks in several
clusters to highlight stage-specific co-occurences between TFBSs. Our approach has
revealed clusters that are either common (NFAT or HMGIY clusters) or specific (SMAD
or AP-1 clusters) for the individual stages. Several of these clusters are likely to play an
important role during the cardiomyogenesis. Further, we have shown that the related
TFs of TFBSs in the clusters indicate potential synergistic or antagonistic interactions to
switch between different stages. Additionally, our results suggest that cardiomyogenesis
follows the hourglass model which was already proven for Arabidopsis and some
vertebrates. This investigation helps us to get a better understanding of how each stage
of cardiomyogenesis is affected by different combination of TFs. Such knowledge may
help to understand basic principles of stem cell differentiation into cardiomyocytes.
Keywords: cardiomyogenesis, engineered heart muscle, MatrixCatch, Markov clustering, transcription factor
collaboration
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1. INTRODUCTION
Transcription factors (TFs) regulate the expression of genes
and genetic programs to maintain survival and adaption to
the environment in adult organisms as well as in embryo-
and organogenesis. Most of them bind to recognized specific
sequences in the DNA regulatory regions of genes and
modify transcription, such as the assembly of the gene
expression machinery. In mammalian tissues TFs often work
in combinatorial interactions for precise regulation of specific
programs (Boyer et al., 2005; Odom et al., 2006; Hu and
Gallo, 2010; Neph et al., 2012). Such interactions can be
positive, resulting in an enhanced expression of a gene or
negative, resulting in reduced expression of a target gene.
Thus, the identification of co-occurring transcription factor
binding sites (TFBSs) in the promoter regions of regulated genes
indicate potential combinatorial interactions between TFs that
are important for understanding the molecular mechanisms, e.g.,
of tissue development during embryogenesis.
The human heart is the first organ formed during
embryogenesis (Kirby, 2002; Brand, 2003; Buckingham et al.,
2005; Brewer and Pizzey, 2006; Schleich et al., 2013), and it
consists of different cell types, which develop simultaneously and
are regulated by TFs as well as their combinatorial interactions.
Until now, several groups analyzed TFs and their influence
on cardiac development (Ryan and Chin, 2003; Pikkarainen
et al., 2004; Peterkin et al., 2005; Brewer and Pizzey, 2006;
Martin et al., 2010; Shi and Jin, 2010; Turbendian et al., 2013;
Chaudhry et al., 2014; Takeuchi, 2014; Wang and Jauch, 2014).
These studies mainly focus on individual TFs or their related
families e.g., GATA family, TBX family, or NKX2 family (Ryan
and Chin, 2003; Pikkarainen et al., 2004; Miura and Yelon,
2013; Turbendian et al., 2013). However, a detailed analysis of
interactions between TFs and their role in cardiac development is
limited to interactions between known cardiac TFs like NKX2-5
or MEF2 which are essential for the generation of cardiac
tissues from stem cells (Martin et al., 2010; Sylva et al., 2014;
Takeuchi, 2014). A complete survey of potential TF interactions
by co-occurring TFBSs in the promoter regions of genes which
regulate cardiac development is still missing, but needed to
understand embryonic cardiac development, in particular of
cardiomyocytes (CMs).
CMs comprise the most important functional cells in the
human heart (Ye et al., 2013; Sylva et al., 2014). CMs show
a limited potential to regenerate after myocardial infarction or
other cardiovascular diseases (CVDs), which is at maximum 50%
CM renewal per lifetime and less than 1% per year (Bergmann
et al., 2009; Sylva et al., 2014; Takeuchi, 2014). Replacing
CMs in elderly by for example enhanced cardiomyocyte
proliferation may improve the quality of their life, but requires
an understanding of how CMs develop and of how they can be
replaced (Akhurst, 2012; Ye et al., 2013; Euler, 2015).
One approach is to apply tissue engineered myocardium
to restore muscle mass and thus reintroduce contractility
(Zimmermann et al., 2006). Such tissues can be generated from
embryonic stem cells (ESCs), induced pluripotent stem cells
(iPSCs), or parthenogenetic stem cells (Soong et al., 2012; Didié
et al., 2013; Ye et al., 2013; Tiburcy and Zimmermann, 2014).
Controlling cardiomyogenesis in vitro requires insight into
biological processes governing embryonic heart development.
To understand cardiac development from a systems biology
perspective, identification of the mechanisms controlling the
expression of fate determining TFs and their regulation of
transcription are of fundamental importance. Co-occurring
TFBSs in the regulatory regions of genes which are specific for
a particular developmental stage reveal potential TF interactions
that are likely to regulate these stages. There are in fact plenty
of TF-TF interactions known as implicated in organogenesis, but
the specific time points when particular interactions occur, are
difficult to obtain and mostly not annotated in public databases.
Only intense literature surveys provide such information.
Recent studies identifying the co-occurrence of TF pairs focus
either on combinatorial approaches where e.g., specific DNA-
sequences bound by different TFs simultaneously were selected
from a library of random sequences (Jolma et al., 2015) or
approaches that focus on data integration e.g., ChIP-seq, SELEX
together with Hi-C to reveal long-range chromatin interactions
(Jolma et al., 2013; Wong et al., 2016). Although the selection
of interacting TF pairs from a library of random sequences
underpins potential interactions of TFs, it does not give any hints
on the actual interactions in particular cell types or tissues. Data
integration and especially Hi-C technology is very promising for
the future, but currently there is a lack in publicly available data
sets that cover the time dependent organogenesis of the human
heart.
In this study we analyze a time series dataset obtained from
RNAseq at different time points of in vitro cardiomyogenesis
(Hudson et al.; in revision) to identify co-occurring TFBSs
which indicate potential interacting TFs that are crucial for
understanding the gene regulatory mechanisms during the heart
development. The dataset consists of six different time points
(day: 0, 3, 8, 13, 29, and 60) where the gene expression in the
tissue culture was measured by RNAseq. The data comprises
early heart development in general and can be differentiated
in the following major developmental stages: (i) mesoderm
induction stage (day 0–day 3); (ii) cardiac specification stage
(day 3–day 13; early 3–8, late 8–13); (iii) cardiac maturation
stage (day 13–day 60; early 13–29, late 29–60). For each stage
we determined the set of unique differentially expressed genes
(DEGs) utilizing limma on the FPKM-values in the dataset
(Smyth, 2004). To identify specific TF interactions in individual
stages, we analyzed the promoter sequences of corresponding
DEGs employing the MatrixCatch approach (Deyneko et al.,
2013). As a result, we observed a set of co-occurring TFBSs
for each stage whose corresponding TFs are likely to represent
potential core regulators of a particular developmental stage.
Although the analyzed DEGs are unique in each stage, the
identified TFBS pairs are highly overlapping between stages. To
overcome this problem inMatrixCatch results, we further applied
Markov clustering algorithm (MCL; Dongen, 2000) for the
detection of clusters which contain stage specific co-occurrences
between TFBSs. In recent years, MCL has gained great attention
in the bioinformatics community for the detection of high-
quality clusters in biological networks due to its highly effective
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and successful algorithm. Especially, for the clustering of protein-
protein interaction networks, several studies have shown that
MCL is superior to conventional clustering approaches in terms
of detection of high-quality andmore accurate functional clusters
(Brohée and van Helden, 2006; Vlasblom andWodak, 2009; Shih
and Parthasarathy, 2012). These articles encouraged us to utilize
MCL for the elimination of negligible pairs at each stage and thus
for the determination of remaining TFBS pairs, which may play
crucial roles during cardiomyogenesis. To this end, we focused
on clusters whose central binding site is present at almost all
stages, but its partners differ stage-specifically. These clusters may
regulate DEGs in each stage and are likely to be fundamentally
implicated in cardiac muscle development.
2. MATERIALS AND METHODS
In this section we describe the differentially expressed genes
analyzed and the methods applied and partly developed. Our
analysis follows the structure of Figure 1.
2.1. Selection of Differentially Expressed
Genes
The data, available as a FPKM normalized RNAseq time
series, was mapped to corresponding gene symbols (hgnc-
symbols) and further analyzed using limma package from the
Bioconductor project for R with standard procedures (Smyth,
2004; R Core Team, 2015). The time series data describe human
cardiomyogenesis in vitro at time points day 0, 3, 8, 13, 29, and 60,
whereas day 0 resembles blastocyst stage development and day 60
early fetal stages (Hudson et al.; in revision). We calculated DEGs
between two time points which define a particular developmental
stage where: (i) day 0–3 defines the mesoderm induction stage;
(ii) day 3–8 early cardiac specification; (iii) day 8–13 late cardiac
specification; (iv) day 13–29 early cardiac maturation and; (v)
day 29–60 the late cardiac maturation stage (this stage describes
the transition from an embryonic to a fetal cardiac maturation
stage). We filtered the set of all DEGs for protein coding genes
(excluding TFs) and their uniqueness in a stage by comparison
to all other stages with p-value ≤ 0.05 and FDR ≤ 0.01 (see
Supplementary File 1). A heatmap of stage-specific DEGs is
given in Supplementary File 2.
2.2. Promoter Sequences
Using UCSC genome browser (Karolchik et al., 2004), we
extracted for each protein coding gene (RefSeq gene) based on
its annotated transcription start site (TSS) the -1 kb putative
regulatory promoter region.
It is important to note that, according to TSS annotations,
a RefSeq gene can have multiple overlapping promoter regions
which results in overestimation of the importance of some
transcription factor binding sites (TFBSs). Thus, following the
line of PC-TraFF to remove the redundancy between sequences,
we filtered them regarding their TSSs (Meckbach et al., 2015).
Consequently, we used in our analysis only those sequences
which have no overlap.
FIGURE 1 | Flowchart of the analysis applied in this study.
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In this study, the assembly of the hg19 release of the human
genomewas used and only UCSC track refGene annotations were
considered which correspond to the chromosomes chr1-chr22,
chrX, and chrY.
2.3. MatrixCatch Analysis
MatrixCatch is a novel method introduced by Deyneko et al.
(2013) to recognize experimentally verified TF pairs based on the
co-localization of their TFBSs, known as composite regulatory
modulues (CRMs), in single promoters. To detect CRMs in
the individual sequences under study, MatrixCatch scans each
sequence and its reverse complement using a special library of
position weight matrices (PWMs). This library has been specified
by considering the TF binding scores, relative orientations and
distances between TFs that are experimentally known to interact,
as documented in the TRANSCompel database (Kel-Margoulis
et al., 2002). Consequently, the usage of MatrixCatch yields
an important practical advantage since this method provides a
high number of known CRMs in sequences with their biological
interpretation (for details, see Deyneko et al., 2013).
In our study, we applied MatrixCatch to the promoter
sequences of the filtered DEGs of the different heart
developmental stages. As we have recently suggested in
PC-TraFF (Meckbach et al., 2015), we prefer in this study the
usage of TFBS pairs instead of CRMs, since those pairs were
detected in a set of sequences. This indicates the importance of
potential collaborations between corresponding TFs in the gene
set of interest.
2.4. Clustering of Co-Occurring TFBSs
Since MatrixCatch provides all detected TFBS pairs of
experimentally verified TF interactions in promoters, the
detected pairs are highly overlapping between developmental
stages. To differentiate stage specific roles of TFBS pairs, we
first determined the frequency of each pair in MatrixCatch
results. After that, we applied the Markov clustering algorithm
(MCL; Dongen, 2000) which is able to eliminate negligible TFBS
pairs based on their frequencies at each stage. To this end, we
constructed an interaction network based on the TFBS pairs for
each heart developmental stage, where nodes are TFBSs and
edges display the co-occurrences between them.
Let N : =
(
V, E
)
be an undirected interaction network of
TFBS pairs where any two elements (vi, vj ∈ V) of N are
connected by an edge e(vi,vj) belonging to E , if and only if
the corresponding TFBS pair was identified by MatrixCatch.
Further, w(vi, vj) denotes the weight of an edge e(vi,vj), which
represents the observed frequency of the TFBS pair (vi, vj) found
by MatrixCatch in the promoter sequences of genes under study.
Based on the weights of edges, an adjacency matrix An×n of
each network was constructed as
Ai,j =
{
w(vi, vj) if e(vi,vj) ∈ E
0 else.
An×n was then converted into a row stochastic "Markov" matrix
Mn×n, where mi×j represents the transition probability between
nodes vi and vj in the network under study. The most common
way to construct a row stochastic transition matrix M is the
normalization of rows in A to sum to 1. This process can be
simply given as: M = 1−1 · A, where 1 is a n × n diagonal
degree matrix and defined as:
1 =


d1 0 · · · 0
0 d2 · · · 0
...
...
. . . 0
0 0 · · · dn

 =


∑n
j=1 a1j 0 · · · 0
0
∑n
j=1 a2j · · · 0
0 0
. . . 0
0 0 · · ·
∑n
j=1 anj


Based on matrix M, we employed MCL (Dongen, 2000) to
detect densely connected TFBSs in each network. Briefly, the
basic intuition of MCL was based on a simulation of stochastic
flows on the underlying interaction network to separate high-
flow regions from low-flow regions. To this end, Expand and
Inflate operations were applied on M until M reaches its
steady state. While the Expand operation corresponds to matrix
multiplication (M = M ×M), the Inflate operation is used
to increase the contrast between higher and lower probability
transitions by taking each entry mi×j in M to the power of
inflation parameter r > 1. Finally, M was re-normalized into
a row stochastic matrix. The pseudo-code for MCL is given in
Algorithm 1.
Algorithm 1 : Markov Clustering Algorithm
Input:M and r > 1
Output: C: A list of clusters
Methode:
1: t = 0
2: Mt =M
3: repeat
4: t = t + 1
5: Mt = Expand(Mt−1) =Mt−1 ×Mt−1
6: Mt = Inflate(Mt, r) =
{
(mij)
r∑n
k=1(mik)
r
}n
i,j=1
7: untilMt converges
8: C: clusters(Mt)
3. RESULTS
We analyzed a time course data set which covers heart muscle
development in human embryonic stem cell derived tissue
cultures at days 0, 3, 8, 13, 29, and 60 (Hudson et al., in
revision). These time points cover the mesoderm induction stage
(day 0–day 3), the cardiac specification stage (day 3–day 13),
and the cardiac maturation stage (day 13–day 29). We further
defined cardiac specification and cardiac maturation into two
more stages, i.e.,: (i) early cardiac specification and maturation
stage from days 3–8 and days 13–29, respectively; (ii) late cardiac
specification and maturation with transition from embryonic
to fetal stages defined by culture days 8–13 and days 29–60,
respectively. By comparison of neighboring time points, for each
stage, we determined the set of DEGs and filtered them according
to their uniqueness in a particular stage. Afterwards, we utilized
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MatrixCatch to identify co-occurring pairs of TFBSs in the
promoter regions of these DEGs. Consequently, we identified: (i)
63 TFBS pairs based on 429 DEGs for the mesoderm induction
stage; (ii) 82 TFBS pairs based on 1233 DEGs for the early cardiac
specification stage; (iii) 24 TFBS pairs based on 36 DEGs for the
late cardiac specification stage; (iv) 52 TFBS pairs based on 205
DEGs for the early cardiac maturation stage; (v) 76 TFBS pairs
based on 964 DEGs for the late cardiac maturation stage (see
Supplementary File 3).
Due to underlying methodology of MatrixCatch, the detected
TFBS pairs show a large overlap between different stages
although they may play different roles in these stages. To
reduce this drawback of MatrixCatch, we further applied Markov
clustering algorithm that seeks to remove negligible TFBS pairs
by emphasizing the roles of remaining pairs at each stage.
Consequently, we obtained (i) 19 clusters for the mesoderm
induction stage; (ii) 25 clusters for the early cardiac specification
stage; (iii) 11 clusters for the late cardiac specification stage;
(iv) 21 clusters for the early cardiac maturation stage, and
(v) 24 clusters for the late cardiac maturation stage (see
Supplementary File 4).
We focused only on clusters with V$AP1_01, V$HMGIY_Q6,
V$SMAD_Q6_01, and V$NFAT_Q6 binding sites in their center
(see Figure 2), because these clusters contain at least three
interactions and the changes in their constitution provide crucial
information about different cardiac developmental stages. We
analyzed the TFBS pairs in these clusters according to their
potential role in cardiac development. We omitted clusters, when
the expression values of TF genes are below a certain threshold
or their importance in heart development is currently unknown.
For our analysis, we applied a FPKM threshold value of 10, which
discriminates robustly between expressed TF genes and low or
not expressed TF genes.
3.1. AP-1-Cluster
The AP-1-cluster is an assembly of different TFBSs with the
V$AP1_01 binding site in its center (see Figure 2A). As described
in Table 1 and in Figure 3, V$AP1_01 binding site co-occurs
with V$OCT_C binding site during mesoderm induction (< day
3) and early cardiac specification stage (day 3–day 8) and at
late cardiac maturation stage (> day 29). Further, V$AP1_01
co-occurs with V$GATA_Q6 binding site at all stages except days
8–13. Interestingly, a co-occurring pair between V$AP1_01 and
V$HNF4_Q6 binding site was detected only between day 3 and
day 8. Additionally, Figure 3 shows for these TFBSs the related
TF genes which are expressed in at least one time point.
AP-1 is a family of leucine zipper transcription factors (bZIP)
which forms homo- or heterodimers composed of proteins
belonging to JUN or FOS protein families (Shaulian and Karin,
2002; Hess et al., 2004; Shaulian, 2010). AP-1 plays a role in the
regulation of general functions like proliferation, differentiation,
and apoptosis. We identified that V$AP1_01 co-occurs with
V$OCT_C binding sites which are bound by AP-1 and POU-
domain factors like POU5F1, respectively. POU5F1 is also known
as OCT-4, which is an important pluripotency maintenance
factor (Schöler et al., 1990; Nichols et al., 1998; Pesce and Schöler,
2001; Guo et al., 2002). Regarding the expression values, POU5F1
shows higher expression in early stages (< day 8) and is absent
after day 13 (see Figure 4B). This is in contrast to AP-1, where
AP-1 components (FOS as well as JUN) are not present or only
present at reduced levels during early stages, but they show
increased expression values after day 13 (see Figure 4A). This
suggests that AP-1 may not be formed during early stages, where
POU5F1 controls the associated genes, and that during the late
cardiac maturation stage (> day 29) the analyzed genes are under
control of AP-1.
Our analysis identified a co-occurrence of V$AP1_01 with
V$GATA_Q6 binding sites. GATA factors form a protein family
of six zinc finger transcription factors that share a highly
conserved DNA-binding sequence (Orkin, 1992; Ohneda and
Yamamoto, 2002; Pikkarainen et al., 2004; Brewer and Pizzey,
2006). As suggested in Brewer and Pizzey (2006), the family can
be dissected into two subfamilies (GATA-1,2,3 and GATA-4,5,6),
based on their expression levels in different tissues, where only
GATA -4, -5 and -6 are associated with cardio- and organogenesis
(Pikkarainen et al., 2004; Peterkin et al., 2005; Brewer and Pizzey,
2006; Whitfield et al., 2012; Turbendian et al., 2013). We found
only GATA4 and GATA6 to be expressed. Interactions between
GATA-factors and AP-1 are well known, especially co-occurrence
of AP-1 together with GATA-4 in several heart cell types and in
Leydig cells (Herzig et al., 1997; Suzuki et al., 1999; Schröder
et al., 2006; Linnemann et al., 2011; Martin et al., 2012). In
our system, GATA6 was expressed in high amounts during the
mesoderm induction (< day 3) and early cardiac specification
FIGURE 2 | Clusters we focus on in our analysis in the order in which they are analyzed in this study. The clusters comprise all interactions during the
complete time course, identified by employing MatrixCatch and MCL. The constitution of each cluster for a particular stage is shown in the corresponding tables. (A)
shows the AP-1-cluster, Table 1; (B) HMGIY-cluster, Table 2; (C) SMAD-cluster, Table 4; (D) NFAT-cluster, Table 5.
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TABLE 1 | TFBS pairs within the AP-1-cluster.
Day0–Day3 Day3–Day8 Day8–Day13 Day13–Day29 Day29–Day60
V$AP1_01 − V$OCT_C + + − − +
V$AP1_01 − V$GATA_Q6 + + − + +
V$AP1_01 − V$HNF4_Q6 − + − − −
Constitution of co-occurring pairs in the AP-1-cluster, a “+” indicates the presence of a pair; a “−” its absence. During the late stage of cardiac specification (Day8–Day13), the cluster
is completely absent.
FIGURE 3 | Stage specific representation of TFBSs and the expression of associated TF genes, referring to Figure 2A. The encircled nodes represent the
found TFBSs which are connected by color-coded round-edged rectangles which highlight stages where a TFBS pair was found. TF genes which are associated to
TFBSs are linked by dashed lines. The TF genes are represented by color-coded rectangles representing the presence at a partiular time point. The absence of a TF
gene during a particular time point or the absence of a pair during a particular stage is encoded in white. Both, the color-code for the stage specificity as well as for
the gene expression of a TF gene is shown on the bottom right side. TF genes which are associated to a TFBS but are in all time points below the set threshold are
omitted.
stage (day 3–day 8) but was not expressed or only at minor
extent during cardiac maturation (> day 13, see Figure 4C). In
contrast, GATA4 was expressed in high amounts during the late
cardiac specification stage as well as during cardiac maturation
(> day 8). The missing of AP-1 during mesoderm induction
(< day 3) suggests that genes specific for mesoderm induction
might be under control of GATA-6, whereas GATA-4 and AP-
1 may regulate genes during cardiac maturation (> day 13),
synergistically (see Pikkarainen et al., 2004 for the role of GATA-4
and GATA-6).
The role of the co-occurrence between V$AP1_01 and
V$HNF4_Q6, which represents a binding site for HNF4A or
HNF4G TFs, during cardiomyogenesis is uncertain. This TFBS
pair was detected during early cardiac specification stage (days
3–8), but no expression of the related genes could be found.
As mentioned before, the formation of AP-1 during this stage
at relevant levels is uncertain (see Figure 4A), due to the low
expression of the AP-1 components. Furthermore, the role of
HNF4-genes, which where frequently reported to be associated
with lipid metabolism in the liver (Watt et al., 2003; Chandra
et al., 2013), during cardiac development is still unclear, but may
point to changes in the metabolism at this stage.
3.2. HMGIY-Cluster
The HMGIY-cluster is assembled in a total of five TFBS
pairs (see Figures 2B, 5) with the V$HMGIY_Q6 binding site
in its center. Table 2 shows the co-occurring TFBS pairs of
this cluster and Figure 5 shows for these TFBSs the related
TF genes which are expressed in at least one time point.
The TFBS pair V$HMGIY_Q6 - V$OCT_Q6 was found
during all stages and the co-occurrence between V$HMGIY_Q6
and V$ATF3_Q6 binding sites was found at days 3–8, and
after day 29. Interestingly, we found in this cluster three
binding sites, namely V$NFKAPPAB_01, V$NFKB_Q6_01, and
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FIGURE 4 | (A) Expression of AP-1 factor genes. In orange FOS TF genes are shown, and in blue JUN TF genes. At early stages the expression levels of FOS and
JUN genes which are AP-1 components is rather limited. It is likely that AP-1 cannot be formed due to the low expression of FOS genes. In later stages (> day 13),
AP-1 and especially FOS increases its expression. (B) Expression of TF genes which contain a POU-domain, in blue (POU5F1) and orange (POU2F1) are the two
genes which are above the threshold. POU5F1 which is more abundant than POU2F1 decreases during the time course and was absent after day 13. (C) Expression
of GATA genes, in blue (GATA6) and orange (GATA4) are above the threshold. GATA6 is expressed during the mesoderm induction stage and decreases afterwards,
while GATA4 becomes supreme in subsequent stages. The red lines show a FPKM value of 10 that we consider as threshold for sufficiently expressed genes which
contribute to regulatory effects.
TABLE 2 | TFBS pairs within the HMGIY-cluster.
Day0–Day3 Day3–Day8 Day8–Day13 Day13–Day29 Day29–Day60
V$HMGIY_Q6 − V$OCT_Q6 + + + + +
V$HMGIY_Q6 − V$NFKAPPAB_01 + + − + +
V$HMGIY_Q6 − V$NFKB_Q6_01 + + + + +
V$HMGIY_Q6 − V$NFKB_Q6 + − − − −
V$HMGIY_Q6 − V$ATF3_Q6 + + − − +
Constitution of co-occurring pairs within the HMGIY-cluster, a “+” indicates the presence of a matrix pair; a “−” its absence.
V$NFKB_Q6 which can be bound by the family of NF-
κB-related factors. While the V$HMGIY_Q6 - V$NFKB_Q6
TFBS pair was detected only during the mesoderm induction
stage (<day 3), the co-occurrence between V$HMGIY_Q6 and
V$NFKB_Q6_01 binding sites was found at all stages. The TFBS
pair V$HMGIY_Q6 - V$NFKAPPAB_01 was found at all stages
except the late cardiac specification stage (day 8–day 13). To
ensure the quality of these three NF-κB binding sites, we further
investigated their position weight matrices (PWMs) as well as
their binding motifs. Considering the PWMs, we observed that
all PWMs have relatively high value of information content (see
Table 3) which assess their quality. In addition, a comparison
between motifs shows different binding behavior of NF-κB-
related factors which could be linked to specific members of this
family.
HMGA1 is a TF which is represented by the PWM
V$HMGIY_Q6 and was recently described as a positive regulator
of pluripotency in cellular reprogramming (Shah et al., 2012).
The expression levels of HMGA1 in our system are in agreement
with previous studies, which describe HMGA1 as highly
abundant during embryogenesis, especially in embryonic stem
cells; with intermediate expression levels in undifferentiated
cancers and at low or at not detectable levels in adult
differentiated cells and fibroblasts (Fusco and Fedele, 2007;
Hillion et al., 2008, 2009; Resar, 2010; Chou et al., 2011;
Schuldenfrei et al., 2011; Shah et al., 2012; Williams et al.,
2015). The detected co-occurrence between V$HMGIY_Q6
and V$OCT_Q6 binding sites was found at all stages. The
corresponding TF genes (HMGA1, HMGA2, and POU5F1) of
this TFBS pair did not show such behavior (see Figures 4B, 6A).
HMGA1 as well as POU5F1 are expressed at high levels during
early cardiac development with their maximum expression levels
at day 3 and declined afterwards. However, this pair was found
at later stages indicating that the detected DEGs at these stages
could be potentially regulated by this pair. POU5F1 is below
the threshold after day 13, whereas HMGA1 is always above
the threshold but stablized at low levels. After day 13, HMGA1,
which is in its expression values always more abundant than
HMGA2, could regulate the detected pairs alone.
The co-occurrence of V$HMGIY_Q6 and different NF-κB
binding sites was detected at all time points (see Table 2).
Interestingly, our findings show that this interaction could occur
based on different NF-κB binding sites which are bound by the
same TFs. It is known that the interaction between HMGA1
and NF-κB plays a pivotal role in formation of an enhancer
complex which is essential to regulate interferon-β signaling on
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FIGURE 5 | Stage specific representation of TFBSs and the expression of associated TF genes, referring to Figure 2B. The encircled nodes represent the
found TFBSs which are connected by color-coded round-edged rectangles which highlight stages where a TFBS pair was found. TF genes which are associated to
TFBSs are linked by dashed lines. The TF genes are represented by color-coded rectangles representing the presence at a partiular time point. The absence of a TF
gene during a particular time point or the absence of a pair during a particular stage is encoded in white. Both, the color-code for the stage specificity as well as for
the gene expression of a TF gene is shown on the bottom right side. TF genes which are associated to a TFBS but are in all time points below the set threshold are
omitted.
genomic level (Thanos and Maniatis, 1992; Lewis et al., 1994;
Wood et al., 1995; Himes et al., 1996; Thanos andManiatis, 1996;
Mantovani et al., 1998; Perrella et al., 1999; Zhang and Verdine,
1999). Within this complex, NF-κB acts on the one hand as
a key regulator in hypertrophy and, on the other hand it acts
as cardioprotective factor during embryogenesis (Dewey et al.,
2011; Gordon et al., 2011; Liu et al., 2012; Zhou et al., 2013).
The expression levels of NF-κB genes may indicate an increasing
importance of NFKB1 and especially of RELA during cardiac
maturation (> day 13), where it is expressed at considerable levels
(see Figure 6B).
The co-occurrence of V$HMGIY_Q6 with the V$ATF3_Q6
binding site, which is bound by ATF3, was detected during early
cardiac development until day 8 and at the latest stage after day
29. ATF-3 is a FOS-related TF, which contains a basic leucine
zipper as structural motif (Chen et al., 1994). ATF-3 acts as
homo- or heterodimer to activate or to repress the expression
of target genes, depending on its environment. Further, it is also
involved in TGF-β signaling in several cell types and in cardiac
development (Ishiguro et al., 2000; Mayr and Montminy, 2001;
Yan et al., 2005; Gilchrist et al., 2006; Yin et al., 2010; Lin et al.,
2014). While HMGA1 is expressed at high levels during early
stages (days 0–3) and is declined afterwards, the ATF3 gene is
close to the threshold before day 13 and increases its expression
levels during subsequent stages (see Figure 6C). Our results
suggest that the genes regulated by this pair are under control of
HMGA1 in the early stages and ATF-3 afterwards. Gilchrist et al.
TABLE 3 | Binding sites for different NF-κB PWMs found in the
HMGIY-cluster.
PWM Information Motif
content
V$NFKAPPAB_01 11.8
V$NFKB_Q6_01(rc) 13.3
V$NFKB_Q6 14.4
The family of NF-κB-related factors can be represented by different PWMs each of
which have relatively high information content and different binding motifs. (rc): reverse
complement
demonstrate the co-occurrence of ATF-3 and NF-κB binding
sites in regulated target genes (Gilchrist et al., 2006). According to
their binding sites, our analysis suggests that together with ATF-
3 and NF-κB factor, HMGA1 may play an important role in the
regulation of target genes in cardiac development.
3.3. SMAD-Cluster
The SMAD-cluster is assembled in a total of three TFBS
pairs with the V$SMAD_Q6_01 binding site in its center
(see Figures 2C, 7) . Table 4 shows the co-occurrence of
V$SMAD_Q6_01 and V$FOX_Q2 binding sites in the promoters
of the regulated genes and was observed during all stages. The
TFBS pair V$SMAD_Q6_01 - V$AP1FJ_Q2 was detected in our
system at early stages until day 8 and at late stages after day
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FIGURE 6 | Expression of corresponding TF genes which can be represented by the PWM V$OCT_Q6 have been shown in Figure 4B. (A) Expression of
corresponding TF genes which can be represented by the PWM V$HMGIY_Q6. HMGA1 is dominant over HMGA2 but decreases during the time course. (B)
Expression of corresponding TF genes which can be represented by the PWMs (V$NFKAPPAB_01, V$NFKB_Q6_01, V$NFKB_Q6) related to NF-κB binding sites.
While NFKB2 never reaches the threshold, RELA and NFKB1 increase their expression levels in later stages (> day 13). (C) Expression of the corresponding ATF3
gene to its TF which can be represented by the PWM V$ATF3_Q6. ATF3 is present in the first stage, but in subsequent stages until day 13 it is quite close to the
threshold. It changes its expression levels drastically during the cardiac maturation stage (> day 13). The red lines show a FPKM value of 10 that we consider as
threshold for sufficiently expressed genes which contribute to regulatory effects.
13, but not during late cardiac specification stage (days 8–13).
In contrast, the co-occurrence between V$SMAD_Q6_01 and
V$LEF1TCF1_Q4 was detected only during cardiac specification
(days 3–13). In addition, Figure 7 shows for these TFBSs the
related TF genes which are expressed in at least one time point.
SMADs are members of a family of transcription factors
that form a beta-hairpin structure which interacts with the
major groove of the DNA (Burke et al., 1976; Macias et al.,
2015). SMAD1-4 which can be represented by the PWM
V$SMAD_Q6_01 act as TFs in the nucleus and as signaling
molecules, where they are involved in numerous pathways like
canonical and non-canonical SMAD-signaling pathways, TGF-
β- as well as BMP- and WNT-signaling (Heldin et al., 1997;
Leask and Abraham, 2004; Euler-Taimor and Heger, 2006; Pal
andKhanna, 2006; Schröder et al., 2006; Leask, 2007; Ruiz-Ortega
et al., 2007; Calvieri et al., 2012; Massagué, 2012; Dyer et al.,
2014; Euler, 2015). Figure 8A shows that SMAD1, SMAD2,
and SMAD4 genes are continuously expressed at all stages. The
detected SMAD3 expression after day 3 exceeds the set threshold
only slightly. SMAD2 and SMAD4 show the highest expression
levels in our system, but the differences in their expression levels
are rather small.
The co-occurrence of V$SMAD_Q6_01 and V$FOX_Q2
binding sites was detected at all stages (see Table 4). Recently,
the cooperative regulatory interaction of FOX factors, which play
an important role in cardiovascular development and in other
organs (Yamagishi et al., 2003; Maeda et al., 2006; Seo and Kume,
2006; Fortin et al., 2015), with SMAD3 and SMAD4 has been
shown by (Fortin et al., 2015). Although the SMAD-FOX pair
can be detected during the whole time course, the expression of
FOX-genes is limited to FOXH1, which seems to play a role in
early heart development only (< day 13, see Figure 8C).
The co-occurrence between V$SMAD_Q6_01 and
V$AP1FJ_Q2 binding sites were found in almost all stages
except for the late cardiac specification stage (between day 8
and day 13). In adult CMs, AP-1 together with SMAD proteins
modulates hypertrophic, apoptotic and fibrotic pathways.
Additionally, AP-1 together with SMAD forces the shift toward
apoptosis after stimulation of TGF-β-signaling (Schneiders et al.,
2005; Schröder et al., 2006; Euler, 2015). In the embryonic hearts,
the activation of TGF-β-pathways results in an induction of
cardioprotective functions (Leask and Abraham, 2004; Pal and
Khanna, 2006; Leask, 2007; Ruiz-Ortega et al., 2007; Calvieri
et al., 2012; Euler, 2015). Although there is no known AP-1
SMAD interaction during cardiogenesis, Yuan et al., shows the
interaction of these TFs by usage of AP-1 and SMAD decoy
oligodeoxynucleotides, which reduces fibrosis in their study
(Yuan et al., 2013).
The detected TFBS pair V$SMAD_Q6_01 - V$LEF1TCF1_Q4
is limited to the cardiac specification stage (day 3–day 13).
TCF-7 and LEF-1 transcription factors, which are represented
by V$LEF1TCF1_Q4, can be activated by β-catenin and are
involved in canonical WNT-signaling (Brade et al., 2006; Chen
et al., 2006; Pal and Khanna, 2006; Kwon et al., 2007; Naito
et al., 2010). The measured gene expression of TCF as well as
LEF genes shows that during cardiac specification both groups
are quite close to or below the set threshold (see Figure 8B).
This indicates that no TCF or LEF binding occurs, which may
result in the absence of canonical WNT-signaling during cardiac
specification.
3.4. NFAT-Cluster
The NFAT-cluster consists in a total of six TFBS pairs with
V$NFAT_Q6 binding site in its center (see Figures 2D, 9). As
described in Table 5 and Figure 9, V$NFAT_Q6 co-occurs with
V$PEBP6_Q6 and V$ETS1_B binding sites only during the
mesoderm induction stage (days 0–3). Three TFBS pairs, namely
V$NFAT_Q6 - V$AP1_C, V$NFAT_Q6 - V$CREBP1CJUN_01,
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FIGURE 7 | Stage specific representation of TFBSs and the expression of associated TF genes, referring to Figure 2C. The encircled nodes represent the
found TFBSs which are connected by color-coded round-edged rectangles which highlight stages where a TFBS pair was found. TF genes which are associated to
TFBSs are linked by dashed lines. The TF genes are represented by color-coded rectangles representing the presence at a partiular time point. The absence of a TF
gene during a particular time point or the absence of a pair during a particular stage is encoded in white. Both, the color-code for the stage specificity as well as for
the gene expression of a TF gene is shown on the bottom right side. TF genes which are associated to a TFBS but are in all time points below the set threshold are
omitted.
TABLE 4 | TFBS pairs within the SMAD-cluster.
Day0–Day3 Day3–Day8 Day8–Day13 Day13–Day29 Day29–Day60
V$SMAD_Q6_01− V$FOX_Q2 + + + + +
V$SMAD_Q6_01 − V$AP1FJ_Q2 + + − + +
V$SMAD_Q6_01 − V$LEF1TCF1_Q4 − + + − −
Constitution of co-occurring pairs within the SMAD-cluster, a “+” indicates the presence of a pair; a “−” its absence.
and V$NFAT_Q6 - V$MAF_Q6_01, were found during the
complete time course. The co-occurrence of V$NFAT_Q6 with
V$CEBPB_01 binding sites in the promoter regions of the
analyzed set of genes was found as present until day 8 and during
the cardiac maturation stage after day 13. This TFBS pair was not
present during the late cardiac specification stage (days 8–13). In
addition, Figure 9 shows for these TFBSs the related TF genes
which are expressed in at least one time point.
Regulatory roles for NFAT factors, which can be represented
by the PWM V$NFAT_Q6, have been discovered in diverse
organs and cells, including the central nervous system, blood
vessels, heart, skeletal muscle and haematopoietic stem cells
(Macián, 2005). In general, an activation of factors of the NFAT
family is calcium dependent and has been described to be of
specific importance in development of the atrial myocardium and
the morphogenesis of heart valves (Graef et al., 2001; Crabtree
and Olson, 2002; Schubert et al., 2003; Schulz and Yutzey, 2004).
In our system, only NFATC3 and NFATC4 showed expression
levels above the threshold. Comparing the expression levels,
NFATC4 is more abundant than NFATC3 at all time points,
except for day 3, but both genes increase their expression levels
at later stages and especially after day 29 (see Figure 10A).
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FIGURE 8 | Expression of corresponding TF genes which can be represented by the PWM V$AP1FJ_Q2 have been shown in Figure 4A. (A) Expression of
corresponding genes to TFs which can be represented by the PWM V$SMAD_Q6_01. Each SMAD is expressed during the complete time course at similiar levels,
while the expression levels of SMAD2/4 are higher than the expression levels of SMAD1/3. After beginning of the cardiac specification (> day 3) SMAD4 is slightly
more abundant than SMAD2 and remains in this position. (B) Expression of corresponding TF genes which can be represented by the PWM V$LEF1TCF1_Q4, TCF7
is below the threshold set by us as a limit for robust transcription while LEF1 is clearly transcribed after the mesoderm induction stage (> day 3). The
SMAD-TCFLEF-pair was found during the cardiac specification stage only (day 3–day 8). (C) Expression of corresponding TF genes which can be represented by the
PWM V$FOX_Q2. FOXH1 is the only expressed gene and present until day 13. The red lines show a FPKM value of 10 that we consider as threshold for sufficiently
expressed genes which contribute to regulatory effects.
FIGURE 9 | Stage specific representation of TFBSs and the expression of associated TF genes, referring to Figure 2D. The encircled nodes represent the
found TFBSs which are connected by color-coded round-edged rectangles which highlight stages where a TFBS pair was found. TF genes which are associated to
TFBSs are linked by dashed lines. The TF genes are represented by color-coded rectangles representing the presence at a partiular time point. The absence of a TF
gene during a particular time point or the absence of a pair during a particular stage is encoded in white. Both, the color-code for the stage specificity as well as for
the gene expression of a TF gene is shown on the bottom right side. TF genes which are associated to a TFBS but are in all time points below the set threshold are
omitted.
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TABLE 5 | TFBS pairs within the NFAT-cluster.
Day0–Day3 Day3–Day8 Day8–Day13 Day13–Day29 Day29–Day60
V$NFAT_Q6 − V$PEBP_Q6 + − − − −
V$NFAT_Q6 − V$AP1_C + + + + +
V$NFAT_Q6 − V$CEBPB_01 + + − + +
V$NFAT_Q6 − V$CREBP1CJUN_01 + + + + +
V$NFAT_Q6 − V$MAF_Q6_01 + + + + +
V$NFAT_Q6 − V$ETS1_B + − − − −
Constitution of the NFAT-cluster, a “+” indicates the presence of a matrix pair; a “−” its absence.
The detected co-occurrence of TFBS pairs V$NFAT_Q6 -
V$AP1_C and V$NFAT_Q6 - V$PEBP_Q6 refers either to
NFAT-AP-1 or to NFAT-RUNX interactions which have been
mainly observed in the immune system (Macián, 2005). Macián
et al. have demonstrated that the interaction between NFAT
and AP-1 can be linked to calcineurin dependent pathways as
well as to regulation of MAP kinase pathways (Macián et al.,
2001). Additionally, NFAT and AP-1 cooperate in naïve T-cells
with RUNX TFs as well as with NF-κB in the promoter of IL-
2 during T-cell activation (see Figures 10C,E) (Hermann-Kleiter
and Baier, 2010). In our system, the low or absent expression
of RUNX indicates no relevance for these factors. However,
the corresponding binding site can be also occupied by CBFB,
which is associated to congenital heart anomalies and is expressed
during all time points (Khan et al., 2006).
We found the co-occurring TFBS pair V$NFAT_Q6 -
V$MAF_Q6_01 at all stages. For the corresponding factors it has
been shown by Hogan et al. that NFAT factors and MAF were
able to activate IL-4 promoters (Hogan et al., 2003). Of all TFs
linked to V$MAF_Q6_01, BACH1 is expressed at all stages and is
alwaysmore abundant than the other genes shown in Figure 10B.
This suggests a synergistic interaction in gene regulation between
these factors during the complete time course. Furthermore,
the interaction between NFAT and MAF factors was observed
simultaneously at classical NFAT-AP-1 interaction sites (Hogan
et al., 2003).
The co-occurrence between V$NFAT_Q6 and V$CEBPB_01
binding sites has been described in liver cell lines by Yang
and Chow (2003). The corresponding factors to this pair seem
to interact in a formation of a composite enhancer complex
(Yang and Chow, 2003). In our system, genes that are linked to
V$CEBPB_01 binding sites are not expressed (see Figure 10F).
The observation of this pair and its potential role in heart
development remains unclear.
The role of the TFBS pair V$NFAT_Q6 - V$ETS1_B, which
was detected during the mesoderm induction stage, remains
unclear. ETS1, a TF gene which can be linked to the PWM
V$ETS1_B, is required for the differentiation of cardiac neural
crest (Gao et al., 2010). Although ETS1 was expressed during the
mesoderm induction stage (days 0–3), its expression is markedly
reduced afterwards. DAXX is another gene that is linked to the
PWM V$ETS1_B and is at all time points more abundant than
ETS1 (see Figure 10D). The DAXX factor inhibits apoptosis in
cardiac myocytes (Zobalova et al., 2008). An interaction between
NFAT and DAXX was not found in literature, and thus the role
of this pair remains unclear.
4. DISCUSSION
Today, it is known that in higher organisms transcription factors
have to interact with each other to regulate gene expression
which leads to a proper development of tissues and organs.
So far, several studies have shown that the co-occurence of TF
binding sites (TFBSs) on sequences is an essential indication
for the identification of interactions between TFs. In this study,
we identified co-occurring TFBS pairs by applying MatrixCatch
algorithm to the promoter regions of five differentially expressed
gene sets, which are based on a time course dataset of developing
human myocardium, modeled in a tissue engineering approach
(Hudson et al., in revision). MatrixCatch is a statistically affirmed
computational method for the recognition of experimentally
verified interactions between TFs according to their TFBS
localizations in promoters. However, MatrixCatch recognizes
based on its underlying algorithm all detectable TFBS pairs
of known interacting TFs in promoter regions. This results in
a huge overlap between recognized pairs at different stages,
although these pairs can play different roles for each stage.
To eliminate this drawback of MatrixCatch to some extent,
we created an interaction network based on the TFBS pairs
for each stage and then applied the MCL algorithm. MCL
differentiates negligible TFBS pairs from densely connected TFBS
pairs within these interaction networks and thus determines
clusters of TFBSs. Such clusters are important to highlight stage
specific co-occurrences of TFBS pairs which provide essential
knowledge in the understanding of molecular mechanism of
cardiac development.
Additionally, we applied our approach to different lengths of
putative promoter regions ([from −500 bp to 0], [from −500 bp
to+100 bp], [from−1000 bp to 0]) to determine the influence of
promoter lengths on the composition of stage-specific clusters.
The results denote that there is a considerably high overlap
between stage-specific clusters derived from different putative
promoter regions (data not shown). Thus, we considered the -
1 kb putative regulatory promoter region for our analysis, which
is consistent with our experience and provides the most reliable
results.
Although, we filtered MatrixCatch outputs using MCL
algorithm to reduce weak co-occurrence of TFBSs in each
stage, we detected in our analysis several clusters as well as
TFBS pairs whose potential role during cardiac development
are unclear. One possible reason for the detection of such pairs
could depend on the underlying methodology of MatrixCatch. It
uses a computational prediction approach which scans promoter
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FIGURE 10 | Expression of TF genes corresponding to their factors and represented by the PWM V$AP1_C have been shown in Figure 4A. (A)
Expression of TF genes which corresponds to NFAT factors represented by PWM V$NFAT_Q6. NFATC3 and NFATC4 are above the set threshold, whereas NFATC3 is
more abundant than NFATC4. (B) Expression of TF genes which can be represented by the PWM V$MAF_Q6_01. MAFB shows expression levels slightly above the
threshold set by us as a limit for robust transcription during the mesoderm induction stage while MAFF is expressed during cardiac maturation (> day 13). BACH1 is
found to be expressed during the complete time course at considerable levels and is always more abundant than all other TF genes, which corresponds to
V$MAF_Q6_01. Additionally, BACH1 increases its expression value after the mesoderm induction stage (> day 3). (C) Expression of TF genes which can be
represented by the PWM V$CREBP1CJUN_01. ATF2 is expressed during the complete time course and increases its expression value in the latest stage. JUN is
expressed at day 0 and after day 13 where it exceeds the expression levels of ATF2. (D) Expression of TF genes which can be represented by the PWM V$ETS1_B.
DAXX is expressed during all time points, but its expression diminishes continuously. Nevertheless, it shows expression levels which are always above ETS1. (E)
Expression of TF genes which can be represented by the PWM V$PEBP_Q6. Only CBFB shows expression above the threshold and was found as continuously
expressed. (F) Expression of CEBPB which can be represented by the PWM V$CEBPB_01. CEBPB is during the complete time course below the set threshold and is
considered to be low or not expressed. The red lines show a FPKM value of 10 that we consider as threshold for sufficiently expressed genes which contribute to
regulatory effects.
sequences and their reverse complements to identify TFBSs
using PWMs. However, computational identifications of TFBSs
generally suffer from high rates of false positive predictions.
Another reason for the detection of those clusters or pairs
could be due to genes which are expressed at high levels but
play different roles in different tissues. As a result, we could
identify such clusters or pairs that might play important roles
in the regulation of those genes in other tissues but not in
heart. For example, we identified the TFBS pair (V$NFAT_Q6 -
V$CEBPB_01) in the NFAT-cluster whose importance has
been shown by Yang and Chow in liver (Yang and Chow,
2003), but the potential role of this pair during the cardiac
development is unclear. In this context, we also observed the
ETS cluster with the V$ETS_Q6 binding site in its center (see
Supplementary File 4). Only some individual components, like
ETS factors, in this cluster are associated with potential cardiac
functionalities. However, considering TFBS pairs in the ETS
cluster, we cannot verify their potential role during the cardiac
development.
Our results suggest that different types of co-occurring TFBS
pairs can be assigned into two main categories: (i) TFBS pairs
which are present in the beginning and in later stages but
absent in at least one of the subsequent stages; (ii) TFBS pairs
which are present during all stages. In our clusters presented in
the Result section, there are different co-occurring TFBS pairs,
like V$AP1_01 - V$OCT_C and V$HMGIY_Q6 - V$ATF3_Q6,
which fall into the first category. Considering the expression
values of TF genes for those pairs, we observed that one TF gene
was highly expressed in the beginning stages while its partner is
expressed at low levels. After the re-occurrence of such a pair
in later stages, the measured expression values of TF genes are
exactly the opposite. Consequently, the related TFs cannot act in
a synergistic manner but rather in an antagonistic manner. Very
drastically, we observed this situation in the expression of AP-
1 components and POU5F1, which can be linked to V$AP1_01
- V$OCT_C TFBS pair (see Figures 4A,B). Due to this finding
we hypothesize that further TFBS pairs, which fall into the
first category, could be helpful to enhance our knowledge on
the combinatorial code underlying transcriptional regulation of
cardiomyogenesis.
This findings could be discussed in the perspective of the
“embryonic hourglass“ which describes high divergence in the
embryonic shape of vertebrates, insects, like Drosophila, and
plants, in early and late developmental stages, but minor
Frontiers in Genetics | www.frontiersin.org 13 March 2016 | Volume 7 | Article 33
Zeidler et al. Computational Detection of Stage-Specific TF Clusters
divergence in mid-stages (Duboule, 1994; Raff and Wolpert,
1996; Kalinka et al., 2010; Quint et al., 2012). In our study, the
number of DEGs as well as the number of identified clusters
is high in early stages, converge to a minimum during the late
cardiac specification stage (day 8–day 13) and increase afterwards
again, which is consistent with the general structure of the
hourglass model. Furthermore, the identified TFBS pairs, which
fall into the first category, could be separated into two different
subsets of genes, the one subset is up-regulated before the late
cardiac specification stage, while the other subset is up-regulated
afterwards and is supposed to regulated cardiac maturation
processes. Our findings support the hourglass model derived
by previous findings in Arabidopsis as well as several animals
(Domazet-Lošo and Tautz, 2010; Kalinka et al., 2010; Quint et al.,
2012).
In contrast to the TFBSs pairs in the first category, the
co-occurrence of TFBS pairs that fall into the second category
seems to indicate a synergistic cooperation between related TFs.
In our presented clusters, we obtained several TFBS pairs like
V$HMGIY_Q6 - V$OCT_Q6, V$SMAD_Q6_01 - V$FOX_Q2,
and V$NFAT_Q6 - V$CREBP1CJUN_01 (for detail see
Tables 2–4). Considering the expression values of corresponding
TF genes for those pairs, we determined that these genes are
regulated similarly. For instance, the TF genes HMGA1 and
POU5F1, which are linked to V$HMGIY_Q6 and V$OCT_Q6,
respectively, are highly expressed during first developmental
stages and diminish their levels after day 3. This condition is also
observed for the TFBS pair V$NFAT_Q6 - V$CREBP1CJUN_01
where the associated TF genes are expressed at low levels in the
beginning and increase their expression levels in later stages.
Altogether, in our study we performed a systematic analysis of
TFBS pairs to address the question of cooperation between TFs
linked to TFBS pairs, which could play a crucial role through five
different cardiac developmental stages. Addressing this question,
our results show that some TFBS pairs can be detected at all
developmental stages. Furthermore, we obtained the same TFBS
pairs at very early and very late stages of the differentiation,
although these stages are completely different in their functions.
Especially considering expression values of related TF genes of
these pairs, we determined that co-occurrence between TFBSs
does not always indicate a synergistic regulation of target genes.
This finding suggests that corresponding TFs of these pairs can be
bound in a mutual exclusive manner, which is important during
cardiac development to differentiate between stem cell programs
and later embryogenic programs.
5. CONCLUSION
We identify transcription factor pairs that drive cardiac
development from stem cells to mature cells in a 60 day time
course dataset. Our approach is motivated by the importance of
potentially interacting transcription factors represented by the
co-occurrence of their TFBSs in the regulated stages specific
genes and their mediated effects. We identified the relevant
pairs employing MatrixCatch method with Markov clustering
algorithm together to highlight stage specific clusters of co-
occurring TFBS pairs. Furthermore, we analyzed the changes
within these clusters to show the specificity of the gene
regulation in cardiac development. Our results demonstrate that
similar pairs potentially regulate different developmental stages
depending on the expression values of the corresponding genes.
This may define switches between embryonic and maturation
programs and could contribute to a better understanding of
embryonic cardiac development.
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